
    
      This was a retrospective, non-interventional, observational study that included participants
      diagnosed with ulcerative colitis (UC) or Crohn's disease (CD) who started treatment with
      biologics between June 2011 and June 2013. The study looked at the impact of the
      co-morbidities on the treatment response in IBD participants.

      The study enrolled 310 patients included both UC and CD patients.

      This multicenter trial was conducted in Spain. Investigator collected retrospective data in a
      single visit from participants who started biologic treatment between June 2011 and June
      2013. Time since participants started biological treatment until study visit or until lack of
      treatment response or until treatment change constituted the reference period for the study.
    
  